[1]Elaine D,Zoe C,Cyrus C. Diagnosis and epidemiology of osteoporosis[J].Curr Opin Rheumatol,2005,(17):456461.
[2]Cooper C,Melton LJ. Epidemiology of osteoporosis[J]. Trends Endocrinol Metab,1992,(3):224229.
[3]朱汉民,方积乾,罗先正,等. 骨量流行病学:中国大陆的骨量变化和平均骨峰值[C]//2007国际骨质疏松大会会刊,2007,47.
[4]李忠武,章明放,赵凤云,等. 白细胞介素1、6 mRNA 在去势大鼠骨组织中的表达及其意义[J].中国骨质疏松杂志,2005,11(4):418422.
[5]Mihara M,Hashizume M,Yoshida H,et al.IL6 / IL6 receptor system and its role in physiological and pathological conditions[J].Clinical Science,2012,122(4):143159.
[6]Kimble RB,Srivastava S,RossPF,et al. Estrogen deficiency in creases the ability of stromal cell to support urine osteoclastogenesis via an interleukin1 and tumor necrosis factormediated stimulation of macrophage colony stimulating factor production [J]. J Biol Chem,1996,271(46):2889028897.
[7]杜义斌,徐翔峰,彭江云.骨疏颗粒治疗老年性骨质疏松症30例疗效观察[J].云南中医中药杂志,2006,27(5):15.
[8]杜义斌,吴洋,段艳蕊,等.骨疏颗粒治疗绝经后骨质疏松症临床观察[J].新中医,2013,45(8):7678.
[9]罗颂平,谈勇.中医妇科学[M].北京:人民卫生出版社,2012:l17119.
[10]李青南,梁念慈,胡彬,等.骨质疏松药物研究指南(美国FDA)的方案简介附去卵巢模型及联合用药[J].中国骨质疏松杂志,1997,3(1):7578.
[11]李知玻,李子锋,章莹,等.TNFα对成骨细胞凋亡作用的探讨[J].中国骨质疏松杂志,2012,(10):892894.
[12]Kwantat S,Padrines M,Thedeyre S,et al. IL5,RANKL,TNFalpha/IL1: interrelations in bone resorption pathophysiology[J]. Cytokine Growth Factor Rev,2004,15(1):4952.
[13]回连强,曹春雨,刘婷,等.黔岭淫羊藿总黄酮对抗维甲酸致大鼠骨质疏松作用的研究[J].中国实验方剂学杂志,2014,20(3):170174.
[14]谢雁鸣,许勇钢,赵晋宁,等.骨碎补总黄酮对去卵巢大鼠骨密度和细胞因子IL6、IL4、TNFα水平的影响[J].中国中医基础医学杂志,2004,10(1):3437.
[15]李亚平.杜仲叶提取物治疗骨质疏松浅见[J].四川中医,1996,14(9):16.
[16]李朝阳,吴铁,黄连芳,等.黄芪水提液与己烯雌酚对去卵巢大鼠骨代谢的影响[J].中草药,1998,29(1):2730.
[1]张生,王海蛟,李玉伟,等.过伸手法复位联合经皮椎体成形术治疗胸腰椎骨质疏松性压缩骨折的疗效观察[J].环球中医药,2013,6(07):496.
ZHANG Sheng,WANG Hai jiao,LI Yu wei,et al.Overextending reduction combined with percutaneous vertebroplasty for the treatment of thoracolumbar vertebral compression fractures due to osteoporosis[J].,2013,6(09):496.